Dexamethasone Modulates the Cytokine Response but Not COVID-19-Induced Coagulopathy in Critically Ill
International Journal of Molecular Sciences · 2023
DOI: 10.3390/ijms24087278 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Mélanie Dechamps und 17 weiteren Autor:innen. Beteiligte Einrichtung: Pôle de Recherche Cardiovasculaire (CARD), Institut de Recherche Expérimentale et Clinique (IREC), Université Catholique de Louvain (UCLouvain), 1200…. Hauptthemen laut MEDLINE: Cytokines, COVID-19. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fondation saint luc, Fondation Saint-Luc.
Abstract (Originalsprache)
Severe forms of coronavirus 2019 (COVID-19) disease are caused by an exaggerated systemic inflammatory response and subsequent inflammation-related coagulopathy. Anti-inflammatory treatment with low dose dexamethasone has been shown to reduce mortality in COVID-19 patients requiring oxygen therapy. However, the mechanisms of action of corticosteroids have not been extensively studied in critically ill patients in the context of COVID-19. Plasma biomarkers of inflammatory and immune responses, endothelial and platelet activation, neutrophil extracellular trap formation, and coagulopathy were compared between patients treated or not by systemic dexamethasone for severe forms of COVID-19. Dexamethasone treatment significantly reduced the inflammatory and lymphoid immune response in critical COVID-19 patients but had little effect on the myeloid immune response and no effect on endothelial activation, platelet activation, neutrophil extracellular trap formation, and coagulopathy. The benefits of low dose dexamethasone on outcome in critical COVID-19 can be partially explained by a modulation of the inflammatory response but not by reduction of coagulopathy. Future studies should explore the impact of combining dexamethasone with other immunomodulatory or anticoagulant drugs in severe COVID-19.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Pôle de Recherche Cardiovasculaire (CARD), Institut de Recherche Expérimentale et Clinique (IREC), Université Catholique de Louvain (UCLouvain), 1200 Brussels, Belgium.
- Department of Cardiovascular Intensive Care, Cliniques Universitaires Saint-Luc, 1200 Brussels, Belgium.
- Department of Clinical Biology, Cliniques Universitaires Saint-Luc, 1200 Brussels, Belgium.
- Department of Pharmacy, Namur Research Institute for Life Sciences (Narilis), 5000 Namur, Belgium.
- Qualiblood, s.a., 5000 Namur, Belgium.
- Inotrem s.a., 54500 Vandoeuvre-les-Nancy, France.
ORCID-Profile: Mélanie Dechamps, Jonathan Douxfils, Laure Morimont, Luc Bertrand
Förderung
- Fondation saint luc
- Fondation Saint-Luc
Zitieren
APA
Dechamps, M., De Poortere, J., Octave, M., Ginion, A., Robaux, V., Pirotton, L., Bodart, J., Gruson, D., Van Dievoet, M. A., Douxfils, J., Haguet, H., Morimont, L., Derive, M., Jolly, L., Bertrand, L., Laterre, P. F., Horman, S., & Beauloye, C. (2023). Dexamethasone Modulates the Cytokine Response but Not COVID-19-Induced Coagulopathy in Critically Ill. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24087278
Vancouver
Dechamps M, De Poortere J, Octave M, Ginion A, Robaux V, Pirotton L, et al. Dexamethasone Modulates the Cytokine Response but Not COVID-19-Induced Coagulopathy in Critically Ill. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24087278
BibTeX
@article{Dechamps2023,
author = {Dechamps, Mélanie and De Poortere, Julien and Octave, Marie and Ginion, Audrey and Robaux, Valentine and Pirotton, Laurence and Bodart, Julie and Gruson, Damien and Van Dievoet, Marie-Astrid and Douxfils, Jonathan and Haguet, Hélène and Morimont, Laure and Derive, Marc and Jolly, Lucie and Bertrand, Luc and Laterre, Pierre-François and Horman, Sandrine and Beauloye, Christophe},
title = {Dexamethasone Modulates the Cytokine Response but Not COVID-19-Induced Coagulopathy in Critically Ill},
journal = {International Journal of Molecular Sciences},
year = {2023},
doi = {10.3390/ijms24087278}
}
EUVIMED